The role of confined placental mosaicism in fetal growth restriction: A retrospective cohort study
Prenatal Diagnosis · 2024-03 · 44 (3) · 289-296
DOI: 10.1002/pd.6533 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Prenatal Diagnosis, online erschienen am 11.02.2024. Verfasst von Geerke M Eggenhuizen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Placenta, Trisomy. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To evaluate which cytogenetic characteristics of confined placental mosaicism (CPM) detected in the first trimester chorionic villi and/or placentas in terms of chromosome aberration, cell lineage involved and trisomy origin will lead to fetal growth restriction and low birthweight.
Methods
Cohort study using routinely collected perinatal data and cytogenetic data of non‐invasive prenatal testing, the first trimester chorionic villi sampling and postnatal placentas.
Results
215 CPM cases were found. Fetal growth restriction (FGR) and low birthweight below the 10 th percentile (BW < p10) were seen in 34.0% and 23.1%, respectively. Excluding cases of trisomy 16, 29.1% showed FGR and 17.9% had a BW < p10. The highest rate of FGR and BW < p10 was found in CPM type 3, but differences with type 1 and 2 were not significant. FGR and BW < p10 were significantly more often observed in cases with meiotic trisomies.
Conclusion
There is an association between CPM and FGR and BW < p10. This association is not restricted to trisomy 16, neither to CPM type 3, nor to CPM involving a meiotic trisomy. Pregnancies with all CPM types and origins should be considered to be at increased risk of FGR and low BW < p10. A close prenatal fetal monitoring is indicated in all cases of CPM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
- Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Obstetrics and Gynecology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Clinical Genetics, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
ORCID-Profile: Geerke M Eggenhuizen, Karin E M Diderich, Malgorzata I Srebniak, Diane Van Opstal
Zitieren
APA
Eggenhuizen, G. M., Go, A. T. J. I., Sauter, Z., Hoffer, M. J. V., Haak, M. C., Geeven, G., Diderich, K. E. M., Joosten, M., van den Born, M., Srebniak, M. I., & Van Opstal, D. (2024). The role of confined placental mosaicism in fetal growth restriction: A retrospective cohort study. Prenatal Diagnosis, 44(3), 289-296. https://doi.org/10.1002/pd.6533
Vancouver
Eggenhuizen GM, Go ATJI, Sauter Z, Hoffer MJV, Haak MC, Geeven G, et al. The role of confined placental mosaicism in fetal growth restriction: A retrospective cohort study. Prenatal Diagnosis. 2024;44(3):289-296. doi:10.1002/pd.6533
BibTeX
@article{Eggenhuizen2024,
author = {Eggenhuizen, Geerke M and Go, Attie T J I and Sauter, Zoë and Hoffer, Mariëtte J V and Haak, Monique C and Geeven, Geert and Diderich, Karin E M and Joosten, Marieke and van den Born, Myrthe and Srebniak, Malgorzata I and Van Opstal, Diane},
title = {The role of confined placental mosaicism in fetal growth restriction: A retrospective cohort study},
journal = {Prenatal Diagnosis},
year = {2024},
volume = {44},
number = {3},
pages = {289--296},
doi = {10.1002/pd.6533}
}
EUVIMED